SEOUL, Nov. 30 (Korea Bizwire) – Pharmaceutical companies are diversifying hangover remedies to cater better to customers, especially foreigners, creating new products in different packaging, industry officials said Wednesday. Handok succeeded in grabbing Chinese customers with its Ready Q Chew, the only jelly-type hangover remedy in the local market, where most of the products are [...]
SEOUL, Nov. 17 (Korea Bizwire) – South Korea’s big three pharmaceutical ranking chart is expected to change this year as sales of Chong Kun Dang Pharmaceutical Corp. in the first three quarters beat those of Hanmi Pharmaceutical Co., the previous No. 3, their regulatory filings showed Thursday. Yuhan Co. held its leading position with 964.4 [...]
SEOUL, Nov. 7 (Korea Bizwire) – South Korea’s pharmaceuticals sector is gaining workforce, having added 27 percent more employees since 2011, data showed on Monday. Figures supplied by the Korea Pharmaceutical Manufacturers Association (KPMA) said 94,500 people were working in 842 companies of the pharmaceuticals industry at the end of 2015, up from 74,000 in [...]
SEOUL, Oct. 31 (Korea Bizwire) – Domestic pharmaceutical firms have started to release sensitive information that may play to their disadvantage, mainly in order to eliminate any misunderstanding or speculation by not disclosing information in advance. The move is also driven by the recent Hanmi Pharmaceutical controversy, in which the company allegedly leaked insider information [...]
SEOUL, Oct. 25 (Korea Bizwire) – Korean pharmaceutical companies are making significant developments in their research of Parkinson’s disease. Parkinson’s is often associated with the elderly, making Korea’s rapidly-aging society more vulnerable to the disease, for which there is no cure. Dong-A ST is set to apply for a phase 2 clinical trial for the [...]
SEOUL, Oct. 17 (Korea Bizwire) – The current news proves that the domestic pharmaceutical industry still places too much emphasis on generics, despite focusing on R&D for new medicine. With the expiration of the patent for Twynsta from the multinational pharmaceutical company Boehringer Ingelheim, close to 100 generics are being released. The industry agrees that [...]
INCHEON, Oct. 4 (Korea Bizwire) – The Songdo International Business District is quickly establishing itself as a new hub for the biotech industry, already housing major pharmaceutical and healthcare enterprises like Samsung BioLogics and CellTrion, and attracting further investment from global firms. According to industry watchers, GE Healthcare and Merck Group will open new training [...]
SEOUL, Sept. 21 (Korea Bizwire) – C&C Research Laboratories (CCRL), a joint pharmaceutical venture between South Korea and Japan, announced Monday that it will finally begin its development processes for atopy and breast cancer medicines. CCRL was established in 1992 as a 50-50 joint venture between Korea’s JW Pharmaceutical and Chugai Pharmaceutical in Japan. It [...]
SEOUL, Aug. 23 (Korea Bizwire) – Korean startup Vital Smith was selected as one of the four finalists of Grants4Apps Accelerator 2016, an open innovation program hosted by pharmaceutical company Bayer to discover and support startups and digital healthcare products. Vital Smith presented ‘b bless’, a smart ovulation predictor that helps women identify their fertile [...]
SEOUL, Aug. 8 (Korea Bizwire) – Samsung BioLogics Co., a biosimilar firm affiliated with Samsung Group, will apply for preliminary approval this week for its initial public offering (IPO), estimated at around 3 trillion won (US$2.68 billion), South Korea’s bourse said Monday. The firm, one of the world’s largest manufacturers of biosimilar medicine, plans to [...]